Aberrant sialylation in cancer: therapeutic opportunities

J Munkley - Cancers, 2022 - mdpi.com
Simple Summary All cells are covered in a thick layer of sugar molecules known as glycans.
Changes to this sugar coat are common in cancer, and in particular cancer cells often …

The distinct roles of sialyltransferases in cancer biology and onco-immunology

M Hugonnet, P Singh, Q Haas… - Frontiers in …, 2021 - frontiersin.org
Aberrant glycosylation is a key feature of malignant transformation. Hypersialylation, the
enhanced expression of sialic acid-terminated glycoconjugates on the cell surface, has …

[HTML][HTML] Mucus sialylation determines intestinal host-commensal homeostasis

Y Yao, G Kim, S Shafer, Z Chen, S Kubo, Y Ji, J Luo… - Cell, 2022 - cell.com
Intestinal mucus forms the first line of defense against bacterial invasion while providing
nutrition to support microbial symbiosis. How the host controls mucus barrier integrity and …

Flavonoids regulate tumor-associated macrophages–from structure-activity relationship to clinical potential

Q Sun, Q Liu, X Zhou, X Wang, H Li, W Zhang… - Pharmacological …, 2022 - Elsevier
In recent years, the strategy for tumor therapy has changed from focusing on the direct killing
effect of different types of therapeutic agents on cancer cells to the new mainstream of multi …

Beneficial autoimmunity improves cancer prognosis

L Zitvogel, C Perreault, OJ Finn… - Nature Reviews Clinical …, 2021 - nature.com
Many tumour antigens that do not arise from cancer cell-specific mutations are targets of
humoral and cellular immunity despite their expression on non-malignant cells. Thus, in …

Sanguisorba officinalis ethyl acetate extract attenuates ulcerative colitis through inhibiting PI3K-AKT/NF-κB/STAT3 pathway uncovered by single-cell RNA sequencing

C Li, L Gong, Y Jiang, X Huo, L Huang, H Lei, Y Gu… - Phytomedicine, 2023 - Elsevier
Background Ulcerative colitis (UC) accounts for the untreatable illness nowadays. Bloody
stools are the primary symptom of UC, and the first-line drugs used to treat UC are …

Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice via inhibiting NLRP3 inflammasome

TY Yu, YM Feng, WS Kong, SN Li, XJ Sun… - Frontiers in …, 2023 - frontiersin.org
Background: Ulcerative colitis (UC) is a chronic recurrent inflammatory bowel disease (IBD).
The conventional drugs for UC may induce severe side effects. Herbal medicine is …

The role of the immune system in IBD-associated colorectal cancer: from pro to anti-tumorigenic mechanisms

S Frigerio, DA Lartey, GR D'haens… - International journal of …, 2021 - mdpi.com
Patients with inflammatory bowel disease (IBD) have increased incidence of colorectal
cancer (CRC). IBD-associated cancer follows a well-characterized sequence of intestinal …

Preventive effect of lycopene in dextran sulfate sodium-induced ulcerative colitis mice through the regulation of TLR4/TRIF/NF-κB signaling pathway and tight …

Y Li, X Pan, M Yin, C Li, L Han - Journal of Agricultural and Food …, 2021 - ACS Publications
The preventive effect and molecular mechanism of lycopene (LP) in dextran sulfate sodium
(DSS)-induced ulcerative colitis (UC) in mice were evaluated. Compared to the DSS group …

Advances in glycopeptide enrichment methods for the analysis of protein glycosylation over the past decade

J Li, J Zhang, M Xu, Z Yang, S Yue… - Journal of …, 2022 - Wiley Online Library
Advances in bioanalytical technology have accelerated the analysis of complex protein
glycosylation, which is beneficial to understand glycosylation in drug discovery and disease …